Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD



Status:Recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 65
Updated:3/15/2019
Start Date:October 27, 2017
End Date:December 27, 2019
Contact:Rachel Middleton, B.A.
Email:Rachel.Middleton@nyspi.columbia.edu
Phone:646-774-8138

Use our guide to learn which trials are right for you!

The purpose of this study is to evaluate the feasibility, acceptability, and potential
usefulness of using a mobile application (nOCD) for treatment of obsessive compulsive
disorder (OCD) in a sample of 25 adults (ages 18-65) in an 8 week trial. nOCD is a free
iOS/Android application that provides treatment strategies. The study team will evaluate the
effect of the application using gold-standard clinician-administered and self-report
measures. Prior to downloading the application, participants will receive 4 (up to 5)
in-person visit (orientation to the app and psychoeducation) and receive brief weekly phone
check-ins. The long-term goal of this study is to use this information to develop new
treatments for patients with OCD. All study procedures will be conducted on site at the New
York State Psychiatric Institute.

The purpose of this study is to evaluate the feasibility, acceptability, and potential
usefulness of using a mobile app (nOCD) for treatment of OCD in a sample of 25 adults (ages
18-65). nOCD is a free iOS/Android app that provides EX/RP-consistent treatment strategies.
The study team will evaluate the effect of the app using gold-standard clinician-administered
and self-report measures. Prior to downloading the app, participants will receive 4 (up to 5)
in-person visits and receive brief weekly phone check-in. The long term goal of this line of
research is to increase access to evidence-based treatment and to ultimately reach more
patients giving them access to tools to reduce their OCD symptoms and improve their quality
of life.

Inclusion Criteria:

- Primary DSM-5 diagnosis of obsessive-compulsive disorder

- Age 18-65

- Not currently receiving psychotherapy focused on OCD symptoms, and no EX/RP within the
past 12 weeks

- For those currently on medication: On a stable dose of psychiatric medication (for at
least 12 weeks)

- Capacity to provide informed consent

Exclusion Criteria:

- Comorbid psychiatric conditions that significantly elevate the risk of study
participation (e.g. psychotic disorders, bipolar disorder, evidence of dementia or
other cognitive disorder, suicidality).
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
646-774-5000
Principal Investigator: Marina Gershkovich, Ph.D.
Phone: 646-774-8138
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
?
mi
from
New York, NY
Click here to add this to my saved trials